Author Index: N

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Naalt, van der, J.
• VARIATION IN TREATMENT DECISIONS IN TRAUMATIC BRAIN INJURY: PREDICTORS AND ASSOCIATIONS WITH OUTCOME
Naimark, D.
• AN INTRODUCTION TO MICROSIMULATION IN HEALTH-STATE TRANSITION MODELS
Nakagawa, S.
• VALUES-CONSISTENT DECISIONS WITH USE OF A PRENATAL TESTING DECISION SUPPORT GUIDE
Nam, A.
• COST-EFFECTIVENESS OF TELEHOMECARE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN CANADA
Nanwa, N.
• BURDEN OF COMMUNITY-ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION IN ONTARIO, CANADA: A POPULATION-BASED STUDY
Narayan, M.
• PATIENT PREFERENCES FOR COMMUNICATION OF TAILORED SURVIVAL ESTIMATES
Nardelli, A.
• ASSISTED REPRODUCTIVE TECHNOLOGIES (ARTS) IN ALBERTA, CANADA: AN ECONOMIC ANALYSIS TO INFORM POLICY DECISION-MAKING
Narendorf, S.
• SYSTEMATIC REVIEW OF SHARED DECISION MAKING INTERVENTIONS FOR INDIVIDUALS WITH MENTAL HEALTH CONCERNS
Negoescu, D.
• DATA-DRIVEN MODELING AND SIMULATION FOR THE DESIGN AND EVALUATION OF HIV VIRAL LOAD MONITORING POLICIES IN RESOURCE-LIMITED SETTINGS
Nelder, M.
• HEALTHCARE COSTS ATTRIBUTABLE TO LYME DISEASE: A POPULATION-BASED MATCHED COHORT STUDY IN ONTARIO, CANADA
Nelson, D.
• ATTITUDES TOWARD SCREENING AND LUNG CANCER RISK PERCEPTIONS AMONG VETERANS INVITED TO AND SCHEDULING LUNG CANCER SCREENING
Nemati, S.
• ANTICOAGULATION THERAPY FOR ATRIAL FIBRILLATION IN PATIENTS WITH DEMENTIA: A COST EFFECTIVENESS ANALYSIS
Neumann, P. J.
• VALUE OF INDIVIDUALIZED INFORMATION IN COST-EFFECTIVENESS ANALYSIS: WHEN IS AN OUTCOME PREDICTION MODEL WORTH USING?
Neylon, E.
• DEVELOPMENT OF AN ONLINE PATIENT DECISION AID FOR PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA

• PATIENT AND HEALTHCARE PROVIDER INVOLVEMENT IN THE DEVELOPMENT OF A PATIENT DECISION AID FOR THOSE WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Ng, C.
• A MODEL-BASED COMPARISON OF EVALUATION STRATEGIES FOR URINARY TRACT MALIGNANT TUMORS IN PATIENTS WITH ASYMPTOMATIC MICROSCOPIC HEMATURIA
Ng, C. J.
• IDENTIFYING CULTURAL INFLUENCES ON PATIENTS' DESIRED LEVELS OF PARTICIPATION IN MEDICAL DECISION MAKING: A MULTI-CULTURAL INVESTIGATION
Ng, X.
• VARIATION IN CAREGIVER PREFERENCES FOR PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TREATMENTS: A COMPARISON OF STRATIFICATION AND LATENT CLASS ANALYSIS

• DO STAKEHOLDER PREFERENCES FOR ENGAGEMENT IN PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TREATMENT CORRELATE WITH REPORTED OUTCOMES? A BEST WORST SCALING EXPERIMENT
Nghiem, V. T.
• OVERTREATMENT AND COST-EFFECTIVENESS OF SEE-AND-TREAT APPROACH IN MANAGING CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS IN THE US SETTING

• COST-EFFECTIVENESS ANALYSIS OF HIV PREVENTION FOR NEGLECTED, AT-RISK WOMEN IN VIETNAM: IMPLICATIONS FOR PRIORITIZING BEHAVIORAL INTERVENTION RESOURCES
Nguyen, B.
• COST-EFFECTIVENESS OF PROPOFOL VS DEXMEDETOMIDINE FOR MILD TO MODERATE SEDATION DURING MECHANICAL VENTILATION
Nichita, C.
• TRAINING PRIMARY CARE PHYSICIANS IN SHARED DECISION MAKING FOR COLORECTAL CANCER SCREENING. INSIGHTS FROM A STATEWIDE COLORECTAL CANCER SCREENING PROGRAM IN SWITZERLAND
Nieboer, D.
• A CALIBRATION HIERARCHY FOR RISK MODELS: ‘MODERATE' CALIBRATION GUARANTEES NON-HARMFUL DECISION MAKING
Nielsen, M.
• A MODEL-BASED COMPARISON OF EVALUATION STRATEGIES FOR URINARY TRACT MALIGNANT TUMORS IN PATIENTS WITH ASYMPTOMATIC MICROSCOPIC HEMATURIA
North, T.
• IMPLEMENTATION AND ADOPTION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Norton, E.
• CHANGES IN PERFORMANCE IN THE HOSPITAL VALUE BASED PURCHASING PROGRAM AFTER THE ADDITION OF AN EFFICIENCY DOMAIN
Norton, M.
• VALUES-CONSISTENT DECISIONS WITH USE OF A PRENATAL TESTING DECISION SUPPORT GUIDE
Nosyk, B.
• MODELING THE COST-EFFECTIVENESS OF OPIOID AGONIST TREATMENT POLICY ALTERNATIVES IN CALIFORNIA'S PUBLICLY-FUNDED DRUG TREATMENT FACILITIES

• INFORMING RESOURCE ALLOCATION DECISIONS IN HIV/AIDS: A CASE STUDY FOR BRITISH COLUMBIA, CANADA

• PROBABILISTIC MODEL-BASED PATTERN ANALYSIS OF HEALTH RESOURCE USE AMONG PEOPLE LIVING WITH HIV/AIDS
Nowalk, M. P.
• CLASSIFICATION AND REGRESSION TREES (CART) ANALYSIS FOR PREDICTING INFLUENZA
Nowalk, M. P.
• COST EFFECTIVENESS OF INFLUENZA VACCINE OPTIONS IN US ELDERS

• WHICH INFLUENZA VACCINE IS FAVORED IN 2 TO 8 YEAR OLDS? A COST-EFFECTIVENESS ANALYSIS
Nowels, C.
• DEVELOPMENT AND PILOT OF FOUR DECISION AIDS FOR IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS IN DIFFERENT MEDIA FORMATS

• IMPLEMENTATION OF DECISION AIDS FOR IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: LESSONS LEARNED AND PATIENT PERSPECTIVES
Nuanes, H.
• DEVELOPMENT AND PILOT OF FOUR DECISION AIDS FOR IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS IN DIFFERENT MEDIA FORMATS

• IMPLEMENTATION OF DECISION AIDS FOR IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: LESSONS LEARNED AND PATIENT PERSPECTIVES
Nuckols, T.
• THE VALUE OF QUALITY IMPROVEMENT INTERVENTIONS FOR CATHETER-ASSOCIATED URINARY AND BLOOD STREAM INFECTIONS: A SYSTEMATIC REVIEW
Nuyttens, J.
• EXPERT OPINION OF TREATMENT DECISION MAKING IN PATIENTS WITH EARLY STAGE NON-SMALL CELL LUNG CANCER
Nyitray, A.
• VALUE OF ADDITION OF HPV VACCINATION TO ANAL PRECANCEROUS LESION TREATMENT IN OLDER MSM—DO WE NEED FURTHER EVIDENCE?

• ADJUVANT HPV VACCINATION IN OLDER HIV-POSITIVE MEN WHO HAVE SEX WITH MEN FOR PREVENTION OF ANAL CANCER – LONG-TERM CLINICAL AND ECONOMIC BENEFITS
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z